Stock GLUE MONTE ROSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Monte Rosa Therapeutics, Inc.

Equities

GLUE

US61225M1027

Real-time Estimate Cboe BZX
Other stock markets
 11:00:46 15/05/2024 pm IST 		5-day change 1st Jan Change
5.385 USD +7.70% Intraday chart for Monte Rosa Therapeutics, Inc. +2.09% -4.96%
09/05 Monte Rosa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02/05 Monte Rosa Therapeutics, Inc. Announces Departure of Owen Wallace as Chief Scientific Officer and Transition to Member of its Scientific Advisory Board CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Monte Rosa Therapeutics, Inc. Announces Departure of Owen Wallace as Chief Scientific Officer and Transition to Member of its Scientific Advisory Board
CI
Monte Rosa Therapeutics, Inc. Appoints Anthony M. Manning to the Board of Directors
CI
Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors
CI
Monte Rosa Therapeutics Promotes Jullian Jones to Chief Business Officer
MT
Monte Rosa Therapeutics, Inc. Appoints Jullian G. Jones as Chief Business Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLUE Stock
  4. News Monte Rosa Therapeutics, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW